Cyclin D1 promotes androgen-dependent DNA damage repair in prostate cancer cells.
Di Sante, G
Lisanti, Michael P
AffiliationCancer Biology, Thomas Jefferson University.
MetadataShow full item record
AbstractTherapy resistance and poor outcome in prostate cancer is associated with increased expression of Cyclin D1. Androgens promote DNA double strand break repair to reduce DNA damage, and cyclin D1 was also shown to enhance DNA damage repair (DDR). In this study, we investigated the significance of cyclin D1 in androgen-induced DDR using established prostate cancer cells and prostate tissues from cyclinD1 knockout mice. We demonstrate that endogenous cyclin D1 further diminished the dihydrotestosterone (DHT)-dependent reduction of gammaH2AX foci in vitro. We also show that cyclin D1 was required for the androgen-dependent DNA damage response both in vitro and in vivo. Furthermore, cyclin D1 was required for androgen-enhanced DDR and radioresistance of prostate cancer cells. Moreover, microarray analysis of primary prostate epithelial cells from cyclin D1-deficient and wild-type mice demonstrated that most of the DHT-dependent gene expression changes are also cyclin D1-dependent. Collectively, our findings suggest that the hormone-mediated recruitment of cyclin D1 to sites of DDR may facilitate the resistance of prostate cancer cells to DNA damage therapies, and highlight the need to explore other therapeutic approaches in prostate cancer to prevent or overcome drug resistance.
CitationCyclin D1 promotes androgen-dependent DNA damage repair in prostate cancer cells. 2015: Cancer Res
- Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
- Authors: Marampon F, Gravina G, Ju X, Vetuschi A, Sferra R, Casimiro M, Pompili S, Festuccia C, Colapietro A, Gaudio E, Di Cesare E, Tombolini V, Pestell RG
- Issue date: 2016 Feb 2
- 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
- Authors: Qiao Y, Zhang ZK, Cai LQ, Tan C, Imperato-McGinley JL, Zhu YS
- Issue date: 2007 Dec 1
- DNA damage response (DDR) via NKX3.1 expression in prostate cells.
- Authors: Erbaykent-Tepedelen B, Karamil S, Gonen-Korkmaz C, Korkmaz KS
- Issue date: 2014 May
- Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
- Authors: Miyake H, Hara I, Gleave ME, Eto H
- Issue date: 2004 Dec 1
- Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer.
- Authors: Kolár Z, Murray PG, Scott K, Harrison A, Vojtĕsek B, Dusek J
- Issue date: 2000 Feb